Tag Archives: URALCHEM

URALCHEM and the Ziedot.lv Fund present New Year Gifts to seriously ill children in Latvia

URALCHEM and a leading Latvian charity organization, the Ziedot.lv Fund, held New Year activities and events for a group of seriously ill children in Latvia and members of their families. URALCHEM’s CEO, Dmitry Konyaev, and the head of the Ziedot.lv Fund, Ruta Dimanta, gave presents to the children.

Riga, Latvia – December 20, 2012 — URALCHEM and a leading Latvian charity organization, the Ziedot.lv Fund, held New Year activities and events for a group of seriously ill children in Latvia and members of their families. URALCHEM’s CEO, Dmitry Konyaev, and the head of the Ziedot.lv Fund, Ruta Dimanta, gave presents to the children. These children are beneficiaries of a joint charity programme “Help for seriously ill children”, which was launched in the autumn of this year.

In September 2012, URALCHEM and the Ziedot.lv Fund signed an agreement that started a charitable programme for the treatment of 20 children from Latvia in leading Russian clinics. URALCHEM is providing total funding to the amount of €80 thousand.

Since the launch of the programme, 11 families have received help with specific treatment or rehabilitation for their children using leading Russian clinics. The Ziedot.lv Fund has selected clinics and treatment programmes on the basis of doctors’ recommendations and requests from parents for financial assistance. URALCHEM has currently provided €25 thousand of funding.

Dmitry Konyaev came to Latvia to show his support for the children and give them New Year presents. “We are pleased that the company’s social policy in Latvia is generating results already. Together with the Ziedot.lv Fund, we intend to continue our support for the children. They are now on their way to recovery and I wish them success in the coming year in overcoming their problems,” he said.

Ruta Dimanta said that the Fund treated every case individually, choosing leading medical institutions in Russia to carry out the treatments. In clinical cases involving children with rare or complex conditions requiring care outside Latvia and not funded by the state, URALCHEM’s participation enables the provision of hospital and other treatment and support for the children’s’ families. She added, “The condition of the children who have been helped has improved significantly. We are grateful to the Russian doctors and to URALCHEM for their assistance. Our joint programme is gaining momentum and I hope that as a result, next year more families will be able to celebrate this holiday with joy.”

-Ends-

Public Relations Department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@URALCHEM.com
Web: http://www.uralchem.com

URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.

URALCHEM HOLDING P.L.C. Reports the First Nine Months of Year 2012 Unaudited IFRS Financial Results

URALCHEM HOLDING P.L.C. announced its unaudited IFRS financial results for the first nine months of 2012 ending 30 September 2012.

(Moscow, Russia – November 16, 2012) – Revenue increased to US $1,804 million, compared to US $1,556 million in the first nine months of 2011.
– Operating profit increased to US $553 million, compared to US $487 million in the first nine months of 2011.
– Adjusted EBITDA grew to US $632 million, compared to US $560 million in the first nine months of 2011.
– Net profit amounted to US $600 million, compared to US $318 million in the first nine months of 2011.

URALCHEM HOLDING P.L.C. (hereinafter URALCHEM HOLDING or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter called the Group), one of the largest producers of nitrogen and phosphate fertilisers in Russia, announced its unaudited IFRS financial results for the first nine months of 2012 ending 30 September 2012.

Dmitry Konyaev, CEO of URALCHEM, OJSC (part of the Group), commented on the results for the first nine months of 2012: “During nine months of this year the Company showed steady improvement of its financial performance compared to the results for the same period of 2011. To this contributed the acquisition earlier this year of another production unit, Minudobrenia, located in Perm and rising world prices for our main products, ammonia and urea. Looking back at the first nine months, we are optimistic about the full-year results for 2012.”

Financial Results

Revenue in the first nine months of 2012 grew to US $1,804 million, compared to US $1,556 million in the first nine months of 2011. Operating profit amounted to US $553 million compared with operating profit of US $487 million in the first nine months of 2011. Operating profit margin amounted to 31% both in the first nine months of 2012 and in the same period of the previous year.

In the first nine months of 2012, net profit amounted to US $600 million, compared with US $318 million in the same period in 2011.

In the first nine months of 2012 adjusted EBITDA reached US $632 million compared to US $560 million for the same period last year, an increase of 13%. Adjusted EBITDA margin in the first nine months of 2012 comprised 35%, compared with 36% in the first nine months of 2011.

Markets

During the third quarter of 2012, price dynamics for fertilizers and intermediate products were different.

Prices for ammonia in the third quarter showed a significant increase due to growing demand and limited supply. During these three months, the price level rose by $50 / t, and reached $650 / t FOB Port of Yuzhny by the end of September.

In the absence of a strongly marked trend, the urea market was characterized by high volatility. Prices have not shown any significant increase or noticeable reduction, remaining within the limits of $360 to $400 / t FOB the ports of the CIS.

Ammonium nitrate prices mainly matched the dynamics of urea prices during the third quarter.

The global market for phosphate fertilizers in the third quarter of 2012 showed low levels of activity. In September, there has been a downward trend in prices amid a lack of demand in South Asia (India, Pakistan).

Sales

As the demand for the Group’s products both in Russia and abroad was high and stable, the volume of sales in the first nine months of 2012 increased by 16% compared to the same period in 2011 and totalled 4,357 thousand tonnes for all products. Sales of urea, increased by 144%, largely contributed to the rise. Due to high demand in the ammonia market, sales of ammonia increased by 54%, while sales of ammonium nitrate decreased by 6%. Sales of “other chemicals” increased by 19%, mainly due to increased sales of ammonium nitrate for industrial use in the domestic market.

Financial Situation

Increased revenues contributed to the increase of cash generated from operations to US $472 million in the first nine months of 2012 rise, compared to US $330 million in the same period last year.

As at September 30, 2012 the Company’s net debt amounted to US $945 million. The weighted average interest rate in the loan portfolio during the first nine months of 2012 comprised 5.8% per annum compared to 7.9% in the same period last year.

For more information, please visit the company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

URALCHEM HOLDING P.L.C. is a holding company of the URALCHEM Group, which includes four fertilizer manufacturing facilities in Russia. URALCHEM Group is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tons of ammonium nitrate, 2.8 million tons of ammonia, 0.8 million tons of MAP and DAP, 0.8 million tons of complex fertilisers and 1.2 million tons of urea per year. URALCHEM Group is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. URALCHEM Group’s key production assets include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC, Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

URALCHEM OJSC Increases Production in the First Nine Months of 2012

URALCHEM OJSC announces operating results for the first 9 months of 2012.

Moscow, Russia – November 15, 2012 — URALCHEM OJSC announces operating results for the first 9 months of 2012. Production from all the enterprises of the URALCHEM Group increased by 0.5% compared to the same period in 2011, amounting to a total of 4.398 million tonnes. The production of ammonia increased by 9% and there was an 8% increase in the production of urea. The production of chemicals for industrial use increased by 17%, mainly due to increased sales of nitric acid in the domestic market. The production of high-margin products also increased: diammonium phosphate (DAP) was re-launched and the production of complex fertilizers increased by 4%. The manufacture of ammonium nitrate and ammonium phosphate was reduced by 7% and 15% respectively.

Dmitry Konyaev, CEO of URALCHEM, OJSC commented on the operating results for the first nine months of 2012, “Due to a number of successfully implemented modernization and technical upgrading projects, the company’s enterprises worked steadily throughout the first 9 months of 2012. As a result of the market conditions at that time, we focused on increasing the production of ammonia and high-margin products, at the same time reducing production of ammonium nitrate and ammonium phosphate.”

-Ends-

For more information, please visit the company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

URALCHEM and the Ziedot.lv Fund combine to help seriously ill children in Latvia

URALCHEM and the fund of Ziedot.lv, have agreed to work together to help seriously ill children who need specific treatment or rehabilitation using leading Russian clinics.

Riga, Latvia – October 3, 2012 — URALCHEM and a leading charitable organization of Latvia, the fund of Ziedot.lv, have agreed to work together to help seriously ill children who need specific treatment or rehabilitation using leading Russian clinics. URALCHEM will provide funding for the hospitalization and treatment of children to the amount of 80 thousand Euros. A corresponding agreement has been signed today by URALCHEM CEO Dmitry Konyaev and Manager of the Fund Ziedot.lv Ruta Dimanta.

Dmitry Konyaev, CEO of URALCHEM, OJSC:

“Since 2009, URALCHEM has been implementing a large-scale logistics project involving the creation of a terminal for transhipment of mineral fertilizers in the Latvian port of Riga. Traditionally, in all regions where URALCHEM does business, we pursue a socially responsible policy, which aims to address the socio-economic problems of the people of these regions. One of the priorities of our policy has always been to help children. In a joint program with Ziedot.lv we will help families of different nationalities living in Latvia who need financial and medical assistance.”

Ruta Dimanta, Head of the Fund Ziedot.lv:

“The programme will help seriously ill children who need treatment in Russian clinics, and whose families are not able to cover all the costs. URALCHEM’s support is particularly important because the treatment of Latvian residents outside the European Union is not funded by the state. In practice, in cases with rare or complex diseases, it is necessary to seek help outside Latvia. Children deserve to have the highest level of treatment based on modern scientific developments.”

The agreement stipulates that, within a specially designed charity programme – “Help for seriously ill children”, 20 children from Latvia will be treated in leading medical institutions in Russia during the coming year. The programme participants are selected by the fund Ziedot.lv on the basis of doctor’s recommendations and requests from parents for financial assistance. Assistance is needed in the treatment of diseases such as autism, vision recovery, cerebral palsy and developmental delay.

With this initiative by URALCHEM, Latvian children will now be able to access world leading medical treatment not only within the EU but in Russia as well.

-Ends-

Public Relations Department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@URALCHEM.com
Web: http://www.uralchem.com

URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.

URALCHEM HOLDING P.L.C. Reports Unaudited IFRS Financial Results for the First Half of 2012

Moscow, Russia – August 03, 2012 — (For Immediate Release)

– Revenue increased to US $1,261 million, compared to US $1,035 million in H1 2011
– Operating profit increased to US $410 million, compared with US $288 million in H1 2011
– Adjusted EBITDA grew to US $462 million, compared to US $337 million in H1 2011
– Net profit amounted to US $444 million, compared with US $266 million in H1 2011

URALCHEM HOLDING P.L.C. (hereinafter URALCHEM Holding or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter the Group), one of the largest producers of nitrogen and phosphate fertilisers in Russia, announced its unaudited IFRS financial results for the six months ended 30 June 2012.

Dmitry Konyaev, CEO of URALCHEM, OJSC (part of the Group), commented on the results for the first half of 2012, “We achieved good financial results in the first half of this year compared to the same period in 2011. EBITDA increased by more than one-third, sales grew by 18% and reached 3 million tons. The good performance was driven by situation on the urea and ammonium nitrate markets, which was favourable for us, as well as acquisition of Minudobrenia OJSC and our own efforts aimed at improving the efficiency of enterprises, the modernization of production and our responsiveness to changing market needs.”

Financial Results

Revenue for the first half of 2012 grew to US $1,261 million, compared to US $1,035 million in the first half of 2011. Operating profit amounted to US $410 million, or 33% of the revenue, compared with the operating profit of US $288 million, or 28% of the revenue in the first half of 2011.

Net profit for the first half of 2012 amounted to US $444 million, compared to US $266 million in the first half of 2011.

During the first half of 2012, adjusted EBITDA reached US $462 million, compared to US $337 during the same period last year, a rise of 37%. Adjusted EBITDA margin for the first half of 2012 comprised 37% of revenue compared with 33% of revenue for the first half of 2011.

Markets

During the second quarter of 2012 prices of mineral fertilisers and semi-products showed significantly different dynamics. Ammonia prices began to recover due to high demand and limited supply. During the second quarter the price grew by $150/t and by the end of June it reached $600/t FOB at the Yuzhny port.

Prices for urea increased until mid-May and surpassed the peak figures of 2011. Since mid-May there was a significant decline in prices due to low activity of buyers. In late June – early July, the urea market began to show signs of recovery.

Prices for ammonium nitrate repeated the dynamics of the urea market and grew rapidly until mid-May. However, the second half of the quarter was characterized by falling prices for the product, which was also due to low purchasing activity.

The global market of phosphate fertilisers was in the process of recovery during the second quarter of 2012. Due to strong demand in Latin America, spot prices recovered, despite the launch of Chinese products on the market. Market participants are forecasting a stable outlook for the third quarter of the year.

Sales

In the first six months of 2012 the Group’s product sales grew by 18% compared to the same period in 2011 and totalled 3 million tons. Due to the acquisition of OJSC Minudobrenia, Perm, sales of urea and ammonia increased significantly, by 117% and 61% respectively.

Financial Situation

Cash generated from operating activities in the first half of 2012 amounted to US $342 million compared with US $194 million in the first half of 2011.

On 30 June 2012, the Company’s net debt amounted to US $991 million. Interest expenses in the first half of 2012 decreased by US $23 million or 36% compared to the same period last year.

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

URALCHEM HOLDING P.L.C. is a holding company of the URALCHEM Group, which includes four fertilizer manufacturing facilities in Russia. URALCHEM Group is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tons of ammonium nitrate, 2.8 million tons of ammonia, 0.8 million tons of MAP and DAP, 0.8 million tons of complex fertilisers and 1.2 million tons of urea per year. URALCHEM Group is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. URALCHEM Group’s key production assets include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC, Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

URALCHEM Presents its New Sulphur Containing Fertilizer NS 30:7 at Cereals 2012

URALCHEM, the second largest ammonium nitrate producer in the world, is again exhibiting at Cereals, the largest agricultural event in the United Kingdom.

Boothby Graffoe, UK (June 14, 2012) — URALCHEM, the second largest ammonium nitrate producer in the world, is again exhibiting at Cereals, the largest agricultural event in the United Kingdom. This year URALCHEM is presenting to the British market its new nitrogen-sulphur fertilizer, nitrogen sulphate NS 30:7 (17.5 SO3), which has been developed within the company’s sulphur containing product range. The unique production technology used in its manufacture has enabled the creation of a product with excellent physical and chemical properties.

The new fertilizer has been specifically designed to meet the requirements of the crops in the UK, taking into account the specific characteristics of the soil here. The ratio of the two nutrient elements is perfectly balanced for these purposes, with 30% of nitrogen and no less than 7% of sulphur (17.5 SO3). The sulphur in the form of water-soluble sulphate within the new product is fully available for plants.

The results of trials that URALCHEM carried out under different soil and climatic conditions have proved the effectiveness of its sulphur containing nitrogen based fertilizers.

In Great Britain the trials were carried out in collaboration with Harper Adams University College. On the basis of forage grass (pastures), the agricultural effectiveness of URALCHEM’s NS-line fertilizers has been determined in comparison with commercially available ammonium nitrate, CAN, as well as nitrogen sulphate NS 26:13 and NS 27:4. The trials proved that the influence of URALCHEM’s products on yield of forage grass was up to 57% higher than that of the existing fertilizers it was compared with.

“As a member of The Sulphur Institute URALCHEM has long recognized the global problem of soil-based sulphur deficit and it is continually expanding its sulphur containing product line. The UK is one of the leading European nations in terms of environmental protection. Ironically, the effective environmental policies have caused a noticeable reduction of sulphur emission into the atmosphere, which, in its turn, has resulted in harvest yield reduction of important agricultural crops over the last 10 years. Thus, field experiments show that yield losses due to sulphur deficiency in this country can be up to 70% in oilseed rape and up to 50% in cereals”, – said Mikhail Genkin, Business Development Director, URALCHEM. “The company’s researchers are sure that added sulphur components at the market-tailored ratio, along with the overall characteristics of our new product, will help British farmers to significantly increase their crop yields.”

Like other NS-line fertilizers produced by URALCHEM, the new NS 30:7 has excellent storage and spreading characteristics due to superb granule strength and granulometric composition.

URALCHEM expects NS 30:7 to become one of its most successful products in the UK market. The first sales are planned for the summer of this year.

So far, the main groups of fertilizers supplied by URALCHEM to the UK market have been stabilized ammonium nitrate and NPKs. Great Britain and Ireland remain key markets for the company’s complex fertilizers.

Reference information
URALCHEM has been successfully working in the UK and Ireland since late 2008. In 2009 the company determined the British and Irish markets as strategic for the further development of its non-domestic sales. In compliance with the strategy of being a fully recognized participant of the agricultural markets of these countries URALCHEM became the first Russian company to be welcomed in November 2009 as a full member of the Agricultural Industries Confederation.

Since December 2010 URALCHEM has been a certified participant of International Responsible Care Programme, supervised by UNO through United Nations Institute for Training and Research (UNITAR).

In May 2011 URALCHEM Trading SIA, Latvia (a subsidiary of URALCHEM, OJSC) successfully passed FIAS (Fertiliser Industry Assurance Scheme) certification, which proved legislative compliance, security, traceability, safety and good practice in the company’s fertilizer supply chain.

All chemical substances manufactured by URALCHEM are registered with the European Chemicals Agency, the procedure being compliant with Regulation (EU) No 1907/2006 concerning the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH).

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

PR representative in the UK and Ireland
Eva Smit
Tel: +44 (0) 7538 978986
E-Mail: eva.smit@holdensmit.com

URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.

Latin American Contractors See URALCHEM Fertilizer Production in Action

The representatives of the Latin American companies appreciated the high level of production management and quality of fertilizers, noting that their companies considered URALCHEM as a strategic partner.

Moscow, Russia – June 09, 2012 — Representatives of the largest fertilizer consumers in Latin America – Heringer, Dreyfus, ADM, Bunge Argentina and the Association of Argentine Cooperatives (ACA) – visited MFP Kirovo-Chepetsk Chemical Works in Kirovo-Chepetsk (part of the URALCHEM Group).

The guests were shown the entire fertilizer technology chain, from ammonia aggregates to the compound fertilizers shop. The delegation also viewed the packaging line and the warehouse for finished products. The representatives of the Latin American companies appreciated the high level of production management and quality of fertilizers, noting that their companies considered URALCHEM as a strategic partner.

Heringer, Dreyfus, ADM, Bunge and ACA are URALCHEM’s key contractors in Latin America. Together, they consume more than half of agrochemical products in the region.

“For our customers, the quality of products is a decisive factor. A visit to our facilities has made it possible for our partners to prove for themselves that we ensure continuous quality control at all stages of production”, said the Commercial Director of URALCHEM, OJSC Alexei Strakhov.

URALCHEM supplies to Latin American markets ammonium nitrate (including stabilized), urea and MAP. In 2011 the Company shipped 967 000 tons of its products to Brazil and Argentina, which comprised about 10% of the local market.

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

URALCHEM HOLDING P.L.C. Reports IFRS Financial Results for the First Quarter of 2012

URALCHEM HOLDING P.L.C. announced its unaudited IFRS financial results for the first quarter of 2012 ending 31 March 2012.

Moscow, Russia – May 31, 2012 — (For Immediate Release)

– Revenue increased to US $673 million, compared to US $566 million in Q1 2011.
– Operating profit increased to US $178 million, compared with US $160 million in Q1 2011.
– Adjusted EBITDA grew to US $207 million, compared to US $186 million in Q1 2011.
– Net profit amounted to US $354 million, compared with US $174 million in Q1 2011.

URALCHEM HOLDING P.L.C. (hereinafter URALCHEM Holding or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter the Group), one of the largest producers of nitrogen and phosphate fertilizers in Russia, announced its unaudited IFRS financial results for the first quarter of 2012 ending 31 March 2012.

Dmitry Konyaev, CEO of URALCHEM, OJSC (part of the Group), commented on the first quarter of 2012 results, “I am pleased with the Company’s results in the first quarter of this year. We are moving ahead as planned. Net profit in the first quarter of 2012 more than doubled compared to the same period last year. This happened due to the acquisition of Minudobrenia in Perm, as well as the reassessment of our share in the enterprise. Besides, the net profit figure was influenced by a considerable reduction in interest expenses on loans which became possible after we refinanced the loan portfolio last year.”

Financial Results

Revenue for the first quarter of 2012 grew 19% to US $673 million, compared to US $566 million in the first quarter of 2011. Operating profit amounted to US $178 million, or 26% of the revenue, compared with the operating profit of US $160 million, or 28% of the revenue in the first quarter of 2011.

Net profit for the first quarter of 2012 more than doubled, amounting to US $354 million, compared to US $174 million in the first quarter of 2011. Without the reassessment of the Company’s share in Minudobrenia, Perm the net profit growth comprised 15%.

During the first quarter of 2012, adjusted EBITDA reached US $207 million, compared to US $186 million the year before, a rise of 11%. Adjusted EBITDA margin for the first quarter of 2012 comprised 31% of revenue compared with 33% of revenue for the first quarter of 2011.

Markets

In the first quarter of 2012 the prices of fertilizers and intermediates showed significantly different dynamics. Prices for ammonia at the Yuzhny port fell to $70 / t due to low demand, both in agriculture and industry, which coincided with the launch of Qafco V. Market recovery began only in late March.

During January to early February the urea market repeated its dynamics in 2011. However, in mid-February a rapid increase in the price of urea started due to high demand in the U.S. The late Q1/early Q2 price level approached peak figures ??of 2011 even surpassing them at certain markets. Prospects for market development in the second quarter remain optimistic for market participants.

Prices for ammonium nitrate were stable during the first quarter due to high volumes of domestic market shipments.

The global market of phosphate fertilizers in the first quarter of 2012 was characterized by low activity, with prices going down slightly. European demand was limited due to severe weather conditions and financial instability. Moderate recovery in prices occurred in late Q1 due to higher demand in Latin America and the U.S. domestic market.

Sales

In the first quarter of 2012 the Group’s product sales amounted to 1.7 million tons, up 20% compared to the first quarter of 2011. Through the acquisition of OJSC Minudobrenia, Perm in January 2012, sales of urea and of ammonia increased significantly.

Financial Situation

Cash generated from operating activities grew by 4%, from US $167 million in the first quarter of 2011 to US $174 million in the first quarter of 2012.

On 31 March 2012, the Company’s net debt amounted to US $1,076 million. The weighted average interest rate in the loan portfolio for the first quarter 2012 decreased to 5.85% compared to annual 8.0% for the same period last year.

Annex to the press release about the unaudited financial results for the first quarter of 2012

EBITDA is a profit / loss from financial and economic activities during the reporting period, before deduction of income tax on profits, income and interest costs, depreciation and amortization. “Adjusted EBITDA” is EBITDA for the reporting period before goodwill, profit / loss from associates, profit / loss on foreign exchange differences arising on financial performance and profit / loss on operations with derivative financial instruments. Adjusted EBITDA is operating profit before depreciation and amortization and financial results of operations with derivative financial instruments. In accordance with International Financial Reporting Standards (“IFRS”), depreciation and amortization are included in cost structure, and in the selling, general and administrative expenses. IFRS does not require the disclosure and does not describe the calculation of EBITDA and adjusted EBITDA, among other financial indicators, so they can not substitute for net profit for the period when evaluating the results of operations or the measure of cash provided by operating activities when evaluating liquidity. Approach to the calculation of EBITDA and adjusted EBITDA, as described earlier, may not coincide with the approaches used by other companies, therefore, comparability may be limited. We believe that EBITDA and adjusted EBITDA provide useful information to investors because they are indicators of the stability and efficiency of our business and our ability to fund discretionary spending such as capital expenditures, the acquisition of subsidiaries and other investments, as well as indicators of our ability to incur and service debt. IFRS classifies depreciation and amortization to operating costs, while in fact they are distributed to the current period non-cash expenses for the acquisition or creation of fixed assets, incurred in previous periods, and are not affiliated with the movement of funds.

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel: +7 (495) 721 89 89
E-Mail: pr@uralchem.com

URALCHEM Achieved Record Financial and Operating Results in 2011

URALCHEM HOLDING P.L.C. Reports IFRS Financial Results for the year ended 31 December 2011.

Moscow, Russia – March 26, 2012 — URALCHEM HOLDING P.L.C. (hereinafter URALCHEM Holding or the Company), a Cypriot holding company of the URALCHEM Group (hereinafter the Group), one of the largest producers of nitrogen and phosphate fertilizers in Russia, announced its audited IFRS financial results for the year ended 31 December 2011.

Dmitry Konyaev, CEO of URALCHEM, OJSC (a Russian holding company of the Group), commented on the 2011 results: “With the favorable market conditions in 2011 the Group achieved record financial and operating results. The volume of marketable production reached 5 million tons, which is in excess of the planned figures. The acquisition of Minudobrenia, Perm will strengthen the Group’s position in the nitrogen segment and will allow it to produce 18% to 20% of domestic urea. Thus, URALCHEM can now become the second largest urea producer in Russia.”

Financial Results

Revenue for the year 2011 grew to US $ 2,080 million, compared to US $ 1,389 million in 2010. Operating profit amounted to US $ 661 million, or 32% of the revenue, compared with the operating profit of US $ 205 million, or 15% of the revenue in 2010. Profit for the year amounted to US $ 445 in 2011, compared to US $ 35 million in 2010.

During the year ended 31 December 2011, adjusted EBITDA reached US $ 752 million, compared to US $ 309 million the year before, a rise of 143%. Adjusted EBITDA margin for the year 2011 comprised 36% of revenue compared with 22% of revenue for the year ended 31 December 2010.

Markets

The urea market dynamics during the period January to September 2011 were significantly different compared to the same period in 2010; the traditional weakening of the market in the 1st quarter was replaced by a sharp rise in prices, which continued throughout the 2nd quarter and amounted to almost $ 200 / t. Then, after a brief downward correction, prices were restored and stabilized in the range of $ 480 – $ 500 / t FOB Yuzhny port. The main reason for the sharp rise in prices was the imbalance between limited supply and the strong demand from the markets in Asia, Latin America and Africa. In the 4th quarter there was a seasonal slump in prices. The situation was determined by high levels of stocks by traders and producers, as well as by the suppliers’ desire to sell their long positions before the Christmas and New Year holidays.

The ammonium nitrate market during the first half of the year basically repeated the dynamics of urea market. However, during the third quarter, because of the effect of lower demand in all major markets, the prices of ammonium nitrate significantly decreased – back to the level of the beginning of the year. During August – September there were price fluctuations within the range of $ 310 – $ 330 / t FOB CIS. In the fourth quarter the decline in prices for ammonium nitrate was mainly due to pressure from the price of urea.

Since the beginning of 2011, the global market of phosphorus fertilizers was characterized by stable shortages that arose due to the decrease in supply from major sources. Prices increased steadily and in September 2011 reached the level that exceeded the same period the year before by 33%. Large volumes of imports of phosphate fertilizers to South Asia and Latin America during the period from the first to the third quarter 2011 allowed large amounts of stocks to accumulate, which led to the decrease in prices in the fourth quarter.

The NPK market in 2011 basically repeated the dynamics of phosphates.

Sales

Against the background of steady high demand for mineral fertilizers in Russia and abroad for most of 2011, the Group’s sales rose by 7% compared to 2010, amounting to a total of 4,920 thousand tons. Sales of urea increased by 18%, sales of phosphate fertilizers grew by 10%. Sales of “other chemicals” increased by 55% due to the increase of sales of ammonium nitrate for industrial use, as well as launch of export sales of new products.

Financial Situation

Due to the increase in revenue, cash generated from operating activities amounted to US $ 525 million for the year ended 31 December 2011, compared to US $ 135 million for the same period the year before.

On 31 December 2011, the Company’s net debt[2] amounted to US $ 930.8 million. The weighted average interest rate in the loan portfolio for the year ended 31 December 2011 amounted to 6.35% compared to 9.07% for the year ended 31 December 2010.

-Ends-

For more information, please visit the Company web site http://www.uralchem.com or use the following contact information:

PR department
URALCHEM, OJSC
Tel +7 (495) 721 89 89
pr@uralchem.com

URALCHEM HOLDING P.L.C. is a holding company of the URALCHEM Group, which includes four fertilizer manufacturing facilities in Russia. URALCHEM Group is one of the largest producers of nitrogen and phosphate fertilizers in Russia and the CIS with production capacities of over 2.5 million tons of ammonium nitrate, 2.8 million tons of ammonia, 0.8 million tons of MAP and DAP, 0.8 million tons of complex fertilizers and 1.2 million tons of urea. URALCHEM Group is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilizers in Russia. URALCHEM Group’s key production assets include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilizers, OJSC in Voskresensk, Moscow region.

URALCHEM’s Production in 2011 exceeds 5 Million Tonnes

URALCHEM OJSC announces operating results for the year 2011. The production volume of URALCHEM holding enterprises during 2011 increased by 5% compared to 2010.

Moscow, Russia – February 03, 2012 — URALCHEM OJSC announces operating results for the year 2011. The production volume of URALCHEM holding enterprises during 2011 increased by 5% compared to 2010, amounting to a total of 5,093 million tonnes. The production of ammonium nitrate increased by 6%. Due to market conditions, the production of DAP was reduced in favour of increasing the production of more marketable MAP, the output of which increased by 31%. The production of other types of fertilisers grew by 82% due to the increase of sales of new fertiliser products and the start of their export sales. The production of other chemicals grew by 22% due to the increase in domestic sales of sulphuric and nitric acid, as well as the increase in sales of the products by the nitrite-nitrate salt division at the Azot Branch.

Dmitry Konyaev, CEO of URALCHEM, OJSC commented on the operating results for the year 2011: “In 2011, the production volume of URALCHEM enterprises exceeded 5 million tonnes for the first time. With the purchase of OJSC Minudobrenia in Perm the company will strengthen its position in the nitrogen market and will become the second largest producer of urea in Russia.”

-Ends-

PR department
URALCHEM, OJSC
Telephone: +7 (495) 721 89 89
pr@uralchem.com

PR representative in the UK and Ireland
Eva Smit
Tel: +44 (0) 7538 978986
E-Mail: eva.smit@holdensmit.com

URALCHEM, OJSC is one of the largest producers of nitrogen and phosphate fertilisers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is the second largest ammonium nitrate producer in the world and number one in Russia, the second largest producer of nitrogen fertilisers in Russia. Key production assets of URALCHEM, OJSC include Azot Branch of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm; MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk, Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk, Moscow region.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of URALCHEM. We wish to caution you that these statements are only predictions. We do not intend to update these statements and our actual results may differ materially from those contained in our projections or forward-looking statements, including, among others, the achievement of anticipated levels of profitability, growth, cost and synergy of our recent acquisitions, the impact of competitive pricing, the ability to obtain necessary regulatory approvals and licenses, the impact of developments in the Russian economic, political and legal environment, financial risk management and the impact of general business and global economic conditions.